Navigation Links
Elevating Manganese Levels hold back HIV

According to researchers at the Hopkins University, working with yeast have made the unexpected discovery the metal manganese can block the replication of HIV inside cells, a finding that could lead to a whole new class of treatments for the virus that causes AIDS.// A team of researchers at Hopkins University in Baltimore found that, human immunodeficiency virus depends on an enzyme called reverse transcriptase to replicate, and higher than normal levels of manganese lower the activity of a similar enzyme used by a virus-like component of yeast.

Further research determined increasing manganese also lowers the activity of HIV's reverse transcriptase, which could block replication of the virus and help prevent it from causing acquired immune deficiency syndrome.

According to Jef Boeke, professor of molecular biology at Hopkins University, if drugs could be grown that increase manganese levels, it would be a innovative approach to treating HIV. Boeke said his team currently is looking for drugs that do just that. The higher levels of manganese in yeast were caused by a defective gene called PRM1, which produces a protein that shuttles manganese out of cells. The Hopkins scientists, felt that they human equivalent of PRM1 will be a good target for drugs designed to treat HIV infection. Boeke cautioned, however, it is not yet known whether raising manganese levels in humans will have any therapeutic effect.

One of the first treatments for HIV infection, the antiretroviral zidovudine (AZT), targeted reverse transcriptase. The virus is notorious for developing resistance to drugs, however, so new treatments are needed to keep it in check. Drugs that target PRM1 and increase manganese levels may help prevent the development of resistance, Boeke said.

HIV may still develop resistance but "a new class of agents would still be really useful because what has really been successful is combining drugs," he said.

Carl Dief fenbach, associate director for basic sciences in the AIDS program at the National Institutes of Health's Institute of Allergy and Infectious Diseases in Bethesda, Md., said the research was done in a test tube and adjusting metal ion concentrations in the body could have completely different results.

Dieffenbach told UPI the study will spur a flurry of research to further understand whether the PRM1 gene is a viable target to develop drugs around. His first step will be to do a study in mice. At the same time, researchers also can look at people infected with HIV and see if they can detect any with a defect in the PRM1 gene. If they do find a defect, they can determine if they are protected from HIV infection or have a slower progression of disease.


'"/>




Related medicine news :

1. Levels Of Blood Proteins May Help Heart Disease Care
2. Elevated Ozone Levels Hurt Sperm Count
3. High Levels of Protein Linked to Brain Shrinkage
4. Chickens Found To Have High Levels of Arsenic
5. Low Protein Levels A Possible Indicator For A Miscarriage
6. Low Testosterone Levels the Cause Of Depression In Men
7. Weather Found To Play An Important Role In Cholesterol Levels
8. Education Levels Found To Predict Stress
9. Effective Control Of Blood Sugar Levels
10. Elevated Blood Sugar Levels A Risk Factor Of Heart Disease
11. Better Control Of Sugar Levels
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... MN (PRWEB) , ... May 31, 2016 , ... DDL, ... the American Association for Laboratory Accreditation (A2LA) to include ISO 594-1 and ISO 594-2 ... common means of achieving a leak-free connection between two medical devices (e.g. a syringe ...
(Date:5/31/2016)... ... May 31, 2016 , ... Like jewels in a crown, the multiple awards ... is home to Ontario’s leading day spa and one of Canada’s few accredited 5 ... a unique concept to combine spa services with hair and beauty services ...
(Date:5/31/2016)... ... May 31, 2016 , ... The Orthopaedic Research and Education Foundation (OREF) ... David G. Lewallen, MD, began his term as president in March, succeeding John J. ... is OREF’s new president-elect. Richard F. Kyle, MD, will serve as chair, corporate development, ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... 2016 Cool Vendors in Security Infrastructure Protection report by Gartner1 Inc. , Each ... series of research reports evaluating these innovative vendors and their products and services. ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Super Powder, a ... to on the go individuals and dedicated athletes, continues to transform the nutritional supplement ... with whey, pea and milk protein, branched-chain amino acids (BCAA), alkaline minerals, wheat grass, ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 26, 2016   Change Healthcare , ... network solutions and technology-enabled services designed to ... into a strategic channel partnership with SourceMed, ... solutions and revenue cycle management services that ... rehabilitation clinics to optimize revenue, operational efficiency ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... Deutschland und GERMANTOWN, Maryland , ... Zusammenarbeit mit Therawis bedient dringenden ...   QIAGEN N.V. (NASDAQ: ... bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics ... die Onkologie eingegangen zu sein. Ein erstes Projekt ...
Breaking Medicine Technology: